These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 3486333)

  • 1. [Mechanisms of lymphocyte activation in systemic lupus erythematosus].
    Gaspar ML; Alvarez Mon M; Gutiérrez C
    Med Clin (Barc); 1986 Feb; 86(4):175. PubMed ID: 3486333
    [No Abstract]   [Full Text] [Related]  

  • 2. [Studies of the mechanisms of human B-cell activation. II. The role of resting B-cell abnormalities in the pathogenesis of systemic lupus erythematosus].
    Ueda Y; Sakane T; Suzuki N; Takada S; Murakawa Y; Tsunematsu T; Niwa Y; Tsuchiya T
    Ryumachi; 1985 Feb; 25(1):8-14. PubMed ID: 3873711
    [No Abstract]   [Full Text] [Related]  

  • 3. [Blastic lymphocyte transformation in lupus erythematosus and scleroderma].
    Pawińska M; Gliński W; Blaszczyk M; Wranicz A
    Przegl Dermatol; 1973; 60(2):161-6. PubMed ID: 4134109
    [No Abstract]   [Full Text] [Related]  

  • 4. Characterization of T lymphocyte subpopulations responsible for deficient interleukin 2 activity in patients with systemic lupus erythematosus.
    Murakawa Y; Takada S; Ueda Y; Suzuki N; Hoshino T; Sakane T
    J Immunol; 1985 Jan; 134(1):187-95. PubMed ID: 3917275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Biological therapies of systemic lupus erythematosus].
    Olesińska M; Chwalińska-Sadowska H; Mielnik P; Wiesik-Szewczyk E
    Pol Merkur Lekarski; 2006 Mar; 20(117):371-3. PubMed ID: 16780279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunopathologic reactions in systemic lupus erythematosus and rheumatoid arthritis].
    Tarasenko RV
    Vrach Delo; 1974 Feb; (2):24-7. PubMed ID: 4468615
    [No Abstract]   [Full Text] [Related]  

  • 7. The circulating lymphocyte profiles in patients with discoid lupus erythematosus and systemic lupus erythematosus suggest a pathogenetic relationship.
    Wouters CH; Diegenant C; Ceuppens JL; Degreef H; Stevens EA
    Br J Dermatol; 2004 Apr; 150(4):693-700. PubMed ID: 15099365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative studies using the lymphocyte transformation test in chronic and visceral lupus erythematosus].
    Schulze P
    Dermatol Monatsschr; 1973 Jun; 159(6):604-7. PubMed ID: 4796631
    [No Abstract]   [Full Text] [Related]  

  • 9. Suppressor T cell activity in rheumatoid arthritis and systemic lupus erythematosus.
    Sakane T; Taniguchi Y; Honda M; Kotani H
    Ryumachi; 1981; 21 Suppl():115-22. PubMed ID: 6211784
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinico-immunologic parallels in patients with lupus erythematosus and scleroderma].
    Skripkin JK; Somov BA; Butov JS; Bereshnoj JZ
    Allerg Immunol (Leipz); 1972; 18(3):163-6. PubMed ID: 4269348
    [No Abstract]   [Full Text] [Related]  

  • 11. Activation and immunoregulation of human B lymphocyte function: implications in normal and disease states.
    Fauci AS
    Monogr Allergy; 1983; 18():96-105. PubMed ID: 6358871
    [No Abstract]   [Full Text] [Related]  

  • 12. [Studies of antilymphocyte antibodies in sera of patients with systemic lupus erythematosus. Analysis of antibodies to activated T cells].
    Sano H; Kumagai S; Imura H; Uchiyama J; Yodoi J; Maeda M
    Arerugi; 1986 Feb; 35(2):86-95. PubMed ID: 3487301
    [No Abstract]   [Full Text] [Related]  

  • 13. [Immunopathology of systemic lupus erythematosus].
    Hamashima Y
    Arerugi; 1986 Jun; 35(6):379-86. PubMed ID: 3533012
    [No Abstract]   [Full Text] [Related]  

  • 14. [Function and significance of B-lymphocyte defects in the pathogenesis of systemic lupus erythematosus].
    Wollina U
    Dermatol Monatsschr; 1984; 170(2):81-90. PubMed ID: 6202566
    [No Abstract]   [Full Text] [Related]  

  • 15. Induction of costimulation of human CD4 T cells by tumor necrosis factor-related apoptosis-inducing ligand: possible role in T cell activation in systemic lupus erythematosus.
    Tsai HF; Lai JJ; Chou AH; Wang TF; Wu CS; Hsu PN
    Arthritis Rheum; 2004 Feb; 50(2):629-39. PubMed ID: 14872508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular immune responses in systemic lupus erythematosus.
    Tsokos GC; Balow JE
    Prog Allergy; 1984; 35():93-161. PubMed ID: 6385016
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunologic studies on systemic lupus erythematosus.
    Shi SY; Kang KF; Weng MW; Tian RM; Hou AQ
    Chin Med J (Engl); 1985 May; 98(5):336-42. PubMed ID: 3926405
    [No Abstract]   [Full Text] [Related]  

  • 18. [Study of blood lymphocytes in systemic lupus erythematosus].
    Delbarre F; Pompidou A; Kahan A; Brouilhet H; Le Gô A; Amor B
    Pathol Biol (Paris); 1971 Apr; 19(7):379-87. PubMed ID: 4931701
    [No Abstract]   [Full Text] [Related]  

  • 19. [Lupus erythematosus: from clinical aspects to immunopathology].
    Houssiau FA
    Bull Mem Acad R Med Belg; 1999; 154(7-9):309-15; discussion 315-8. PubMed ID: 10855338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Systemic lupus erythematosus and antinuclear factors].
    Le Gô A; Amor B; Kahan A
    Biol Med (1971); 1973 Apr; 2(1):33-50. PubMed ID: 4620250
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.